Novartis Pharma US

      
Novartis provides prescription assistance for TOBI patients in need.

Novartis is committed to providing access to TOBI® (Tobramycin Inhalation Solution, USP)     through the TOBI Patient Assistance Program (PAP). The TOBI PAP provides assistance to patients experiencing financial hardship who have no third-party insurance coverage for their medicine.

To be eligible, patients must:

Be US residents

Not have public or private prescription drug coverage

Meet income eligibility criteria. Income eligibility varies by household size


How to access TOBI PAP:

Patients should call 1-877-TOBI-423 (862-4423) for an initial eligibility screening and obtain a PAP enrollment application via fax or mail

If accepted, patients are eligible to receive TOBI for up to 1 year or until alternate prescription drug coverage is obtained. If patients still need assistance after 1 year, they may re-enroll

For more information, call 1-877-TOBI-423 or visit Novartis by clicking here

   
TOBI has become an important part of Tim’s life.
Read his story
here.
   
Find out how TOBI works to manage Pseudomonas aeruginosa.
Click here
 
   
Cystic Fibrosis Resources